What is HRTS's relative strength rating?

Relative strength percentiles for HRTS are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.

What sector is HRTS in?

HRTS is classified under the Other sector per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.

Is HRTS in a leading sector?

Sector RS percentile is not available for Other at this snapshot. Leading sector status (threshold: Other RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.

How volatile is HRTS?

Volatility metrics for HRTS — average daily range (ADR%), average true range (ATR%), and beta — are not available for the current snapshot. These indicators update daily with each pipeline run.

Does HRTS have a seasonal pattern?

TickerStance computes HRTS's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what HRTS has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did HRTS last report earnings?

No SEC EDGAR filings are linked to HRTS in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Tema ETF Trust Tema Heart & Health ETF (HRTS)

Free

Dossier · Pro

Tema ETF Trust Tema Heart & Health ETF · Other

$38.47▼-0.21%

Neutral · stance 47.8As of Monday, August 24, 2026, posted ~17:00 ET

HRTS is not confirmed as a leader.

3m RS is unavailable, Market Stance is 47.8

Lenses litMarket-wide RS; lit = leaderboard

3 month—pctile

6 month—pctile

1 year—pctile

Classic—IBD pctile

LDR—leadership

0 of 5 lenses litLens definitions methodology

Quality filters0 of 4 pass

ADR%—

A/D—

RVOL—

$ Vol—

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Tema ETF Trust Tema Heart & Health ETF (HRTS) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Other. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

Filed: May 2026

HOLDINGS

Top holdings of HRTS

Top 25 holdings of HRTS by portfolio weight
#	Holding	Weight	Value
1	LLY	11.52%	$6M
2	UNH	5.24%	$3M
3	NOVOB	5.24%	$3M
4	RHHBY	4.50%	$2M
5	MRK	4.27%	$2M
6	TMO	3.97%	$2M
7	JNJ	3.59%	$2M
8	GILD	3.43%	$2M
9	RVMD	3.33%	$2M
10	VRTX	2.93%	$2M
11	DHR	2.66%	$1M
12	ABT	2.61%	$1M
13	BBIO	2.59%	$1M
14	CYTK	2.52%	$1M
15	ABBV	2.40%	$1M
16	BMY	2.09%	$1M
17	TEVA	2.06%	$1M
18	DXCM	1.92%	$996K
19	AMGN	1.91%	$992K
20	EW	1.75%	$907K
21	MCK	1.71%	$888K
22	REGN	1.67%	$866K
23	MDGL	1.45%	$755K
24	BSX	1.42%	$738K
25	ISRG	1.30%	$675K

Showing 25 of 37 holdings.

CONCENTRATION

Portfolio shape

48.0%Top 10 holdings

37Total holdings

37 (100%)Resolved tickers

SECTORS

Sector breakdown

Healthcare

70.1%

Financials

5.2%

Consumer Staples

1.7%

Unclassified

9.7%

FAQ

Fund FAQ

What does HRTS hold?: HRTS holds 37 positions; its three largest are LLY (11.52%), UNH (5.24%), and NOVOB (5.24%) as of May 2026.
How concentrated is HRTS?: The top 10 holdings account for 48.0% of HRTS's portfolio. Highly concentrated in top names.
What sectors does HRTS cover?: HRTS's largest sector exposures are Healthcare (70.1%), Financials (5.2%), and Consumer Staples (1.7%).
How fresh is this data?: Holdings are sourced from SEC N-PORT-P filings, published quarterly with a ~60 day lag. The most recent filing for HRTS is dated May 2026.

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

—

LDR

—

StageWeinstein stage analysis

—

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D ratingaccumulation / distribution

—

RVOL todayvs 50d avg

—

U/D ratiolast 50 sessions

—

Breakout volbreakout day vs 50d avg

—

50d avg $ volumeliquidity proxy

—

Risk profile

How much does it move?

Daily range, ATR, beta, and the math for a 1-ADR stop.

ADR% (20d)avg daily range

—

ATR(14)14-day EMA

—

ATR%ATR as % of close

—

Beta vs SPY90d rolling

—

1-ADR stoprisk from close $38.47

—

Evidence · 3 of 3

Market backdrop

Pull-back risk if Macro turns < 60

Trend44.9Are the major indexes going up or down lately?30% weight Breadth50.6Is the rally broad-based or narrow?30% weight Leadership42.4Who's leading?20% weight Macro59.0What does the credit & rates environment say?20% weight

Stance47.8● Neutral

Public attention · HRTS

Is the crowd watching?

No attention data for this ticker yet — it joins the daily scan once a baseline builds.

FAQ

Frequently asked questions

What is HRTS's relative strength rating?: Relative strength percentiles for HRTS are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.
What sector is HRTS in?: HRTS is classified under the Other sector per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Is HRTS in a leading sector?: Sector RS percentile is not available for Other at this snapshot. Leading sector status (threshold: Other RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
How volatile is HRTS?: Volatility metrics for HRTS — average daily range (ADR%), average true range (ATR%), and beta — are not available for the current snapshot. These indicators update daily with each pipeline run.
Does HRTS have a seasonal pattern?: TickerStance computes HRTS's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what HRTS has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did HRTS last report earnings?: No SEC EDGAR filings are linked to HRTS in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Loading ticker…

HRTS monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	HRTS Jan avg: 2.79% median: 2.17% win: 100% σ: 2.36% n: 3 2023-11-22 → 2026-07-31	HRTS Feb avg: 3.59% median: 1.46% win: 100% σ: 3.97% n: 3 2023-11-22 → 2026-07-31	HRTS Mar avg: -3.45% median: -4.71% win: 33% σ: 4.00% n: 3 2023-11-22 → 2026-07-31	HRTS Apr avg: -3.02% median: -0.44% win: 0% σ: 4.78% n: 3 2023-11-22 → 2026-07-31	HRTS May avg: -0.25% median: 1.99% win: 67% σ: 3.99% n: 3 2023-11-22 → 2026-07-31	HRTS Jun avg: 4.34% median: 4.45% win: 100% σ: 1.40% n: 3 2023-11-22 → 2026-07-31	HRTS Jul avg: 0.21% median: 0.44% win: 67% σ: 2.65% n: 3 2023-11-22 → 2026-07-31	HRTS Aug avg: 4.66% median: 4.66% win: 100% σ: 2.09% n: 2 2023-11-22 → 2026-07-31 (current)	HRTS Sep avg: -0.12% median: -0.12% win: 50% σ: 6.79% n: 2 2023-11-22 → 2026-07-31	HRTS Oct avg: 1.19% median: 1.19% win: 50% σ: 5.77% n: 2 2023-11-22 → 2026-07-31	HRTS Nov avg: 3.46% median: 0.62% win: 67% σ: 5.82% n: 3 2023-11-22 → 2026-07-31	HRTS Dec avg: 0.48% median: -1.66% win: 33% σ: 12.85% n: 3 2023-11-22 → 2026-07-31

HRTS monthly seasonality strip

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

HRTS Jan avg: 2.79% median: 2.17% win: 100% σ: 2.36% n: 3 2023-11-22 → 2026-07-31

HRTS Feb avg: 3.59% median: 1.46% win: 100% σ: 3.97% n: 3 2023-11-22 → 2026-07-31

HRTS Mar avg: -3.45% median: -4.71% win: 33% σ: 4.00% n: 3 2023-11-22 → 2026-07-31

HRTS Apr avg: -3.02% median: -0.44% win: 0% σ: 4.78% n: 3 2023-11-22 → 2026-07-31

HRTS May avg: -0.25% median: 1.99% win: 67% σ: 3.99% n: 3 2023-11-22 → 2026-07-31

HRTS Jun avg: 4.34% median: 4.45% win: 100% σ: 1.40% n: 3 2023-11-22 → 2026-07-31

HRTS Jul avg: 0.21% median: 0.44% win: 67% σ: 2.65% n: 3 2023-11-22 → 2026-07-31

HRTS Aug avg: 4.66% median: 4.66% win: 100% σ: 2.09% n: 2 2023-11-22 → 2026-07-31 (current)

HRTS Sep avg: -0.12% median: -0.12% win: 50% σ: 6.79% n: 2 2023-11-22 → 2026-07-31

HRTS Oct avg: 1.19% median: 1.19% win: 50% σ: 5.77% n: 2 2023-11-22 → 2026-07-31

HRTS Nov avg: 3.46% median: 0.62% win: 67% σ: 5.82% n: 3 2023-11-22 → 2026-07-31

HRTS Dec avg: 0.48% median: -1.66% win: 33% σ: 12.85% n: 3 2023-11-22 → 2026-07-31

Holding

Weight

Value

LLY

11.52%

$6M

UNH

5.24%

$3M

NOVOB

5.24%

$3M

RHHBY

4.50%

$2M

MRK

4.27%

$2M

TMO

3.97%

$2M

JNJ

3.59%

$2M

GILD

3.43%

$2M

RVMD

3.33%

$2M

VRTX

2.93%

$2M

DHR

2.66%

$1M

ABT

2.61%

$1M

BBIO

2.59%

$1M

CYTK

2.52%

$1M

ABBV

2.40%

$1M

BMY

2.09%

$1M

TEVA

2.06%

$1M

DXCM

1.92%

$996K

AMGN

1.91%

$992K

1.75%

$907K

MCK

1.71%

$888K

REGN

1.67%

$866K

MDGL

1.45%

$755K

BSX

1.42%

$738K

ISRG

1.30%

$675K

New positions holdings in HRTS
Holding	Before → after	Δ weight
XENEXenon Pharmaceuticals Inc	— → 0.88%	—
STOKStoke Therapeutics Inc	— → 0.60%	—
MBXMBX Biosciences Inc	— → 0.53%	—
GPCRStructure Therapeutics Inc	— → 0.35%	—

Holding

Before → after

Δ weight

XENEXenon Pharmaceuticals Inc

— → 0.88%

—

STOKStoke Therapeutics Inc

— → 0.60%

—

MBXMBX Biosciences Inc

— → 0.53%

—

GPCRStructure Therapeutics Inc

— → 0.35%

—

Added holdings in HRTS
Holding	Before → after	Δ weight
LLYEli Lilly & Co	10.01% → 11.52%	+1.51 pp
UNHUnitedHealth Group Inc	3.85% → 5.24%	+1.40 pp
RVMDRevolution Medicines Inc	2.21% → 3.33%	+1.12 pp
CYTKCytokinetics Inc	1.47% → 2.52%	+1.05 pp
DXCMDexcom Inc	1.29% → 1.92%	+0.63 pp

Holding

Before → after

Δ weight

LLYEli Lilly & Co

10.01% → 11.52%

+1.51 pp

UNHUnitedHealth Group Inc

3.85% → 5.24%

+1.40 pp

RVMDRevolution Medicines Inc

2.21% → 3.33%

+1.12 pp

CYTKCytokinetics Inc

1.47% → 2.52%

+1.05 pp

DXCMDexcom Inc

1.29% → 1.92%

+0.63 pp

Trimmed holdings in HRTS
Holding	Before → after	Δ weight
JNJJohnson & Johnson	4.85% → 3.59%	−1.26 pp
BSXBoston Scientific Corp	2.47% → 1.42%	−1.04 pp
RHHBYRoche Holding AG	5.46% → 4.50%	−0.97 pp
ABTAbbott Laboratories	3.37% → 2.61%	−0.76 pp
ABBVAbbVie Inc	2.96% → 2.40%	−0.56 pp

Holding

Before → after

Δ weight

JNJJohnson & Johnson

4.85% → 3.59%

−1.26 pp

BSXBoston Scientific Corp

2.47% → 1.42%

−1.04 pp

RHHBYRoche Holding AG

5.46% → 4.50%

−0.97 pp

ABTAbbott Laboratories

3.37% → 2.61%

−0.76 pp

ABBVAbbVie Inc

2.96% → 2.40%

−0.56 pp

Exited holdings in HRTS
Holding	Before → after	Δ weight
MASIMasimo Corp	1.36% → —	—
ASNDAscendis Pharma A/S	0.75% → —	—
CRNXCrinetics Pharmaceuticals Inc	0.64% → —	—
NBIXNeurocrine Biosciences Inc	0.57% → —	—

Holding

Before → after

Δ weight

MASIMasimo Corp

1.36% → —

—

ASNDAscendis Pharma A/S

0.75% → —

—

CRNXCrinetics Pharmaceuticals Inc

0.64% → —

—

NBIXNeurocrine Biosciences Inc

0.57% → —

—

Holdings of HRTS on stock-RS leaderboards
Ticker	Weight	Lens	Rank	Stage
RVMD	3.33%	1Y RS	27	Stage 2
ARWR	1.09%	1Y RS	55	Stage 2
MBX	0.53%	1Y RS	41	Stage 2

Ticker

Weight

Lens

Rank

Stage

RVMD

3.33%

1Y RS

Stage 2

ARWR

1.09%

1Y RS

Stage 2

MBX

0.53%

1Y RS

Stage 2

HRTS is not confirmed as a leader.

Top holdings of HRTS

Portfolio shape

Sector breakdown

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Market backdrop

Is the crowd watching?

Frequently asked questions

HRTS is not confirmed as a leader.

§ Seasonality

Top holdings of HRTS

Portfolio shape

Sector breakdown

What the holdings are doing

Between filings

Leaders inside HRTS

Theme exposure inside HRTS

Funds similar to HRTS

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Market backdrop

Is the crowd watching?

Frequently asked questions

§ Seasonality

What the holdings are doing

Between filings

Leaders inside HRTS

Theme exposure inside HRTS

Funds similar to HRTS

Tema ETF Trust Tema Heart & Health ETF (HRTS) — Stance & relative strength

HRTS is not confirmed as a leader.

Top holdings of HRTS

Portfolio shape

Sector breakdown

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Market backdrop

Is the crowd watching?

Frequently asked questions

Tema ETF Trust Tema Heart & Health ETF (HRTS) — Stance & relative strength

HRTS is not confirmed as a leader.

Top holdings of HRTS

Portfolio shape

Sector breakdown

What the holdings are doing

Between filings

Leaders inside HRTS

Theme exposure inside HRTS

Funds similar to HRTS

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Market backdrop

Is the crowd watching?

Frequently asked questions

What the holdings are doing

Between filings

Leaders inside HRTS

Theme exposure inside HRTS

Funds similar to HRTS